Harvard Bioscience gets covenant waiver, interest rate jumps to SOFR+700bps; going concern doubt

HARVARD BIOSCIENCE INC

Waived defaults for failing Q2 2025 financial covenants; no covenant test for Q3 2025.
Interest rate increased to SOFR+700bps (ABR+650bps); $0.4M fee (1% of debt) payable.
Must take steps toward refinancing by Dec 5, 2025 or face default; mandatory prepayment on refinancing/sale.
Minimum liquidity of $3M required; company warns of substantial doubt about going concern.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.